Larvol Delta - RhoVac39s-Prostate-Cancer-Drug-Candidate-RV001-is-granted-Fast-Track-Designation-by-the-FDA

RV001 - RhoVac

https://www.prnewswire.com/news-releases/rhovacs-prostate-cancer-drug-candidate-rv001-is-granted-fast-track-designation-by-the-fda-301180409.html

Nov 25, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next